# FDA Inspection 1155965 - University Hospitals Cleveland Medical Center IRB - October 22, 2021

Source: https://www.keypedia.com/records/fda_inspections/university-hospitals-cleveland-medical-center-irb/8a52c0b7-c916-491b-891e-98926b83c6ba
Source feed: FDA_Inspections

> FDA Inspection 1155965 for University Hospitals Cleveland Medical Center IRB on October 22, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155965
- Company Name: University Hospitals Cleveland Medical Center IRB
- Inspection Date: 2021-10-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155965 - 2021-10-22](https://www.keypedia.com/records/fda_inspections/university-hospitals-cleveland-medical-center-irb/03e8b7c2-11c0-40ec-98f9-5285cb8edf8c)
- [FDA Inspection 1026089 - 2017-09-19](https://www.keypedia.com/records/fda_inspections/university-hospitals-cleveland-medical-center-irb/b06ac63c-5965-4b19-bb4f-2e6bc2ed1e5f)
- [FDA Inspection 756181 - 2011-12-06](https://www.keypedia.com/records/fda_inspections/university-hospitals-cleveland-medical-center-irb/0568ce35-5e96-4d39-aab7-0e76eb5bb5d8)

Company: https://www.keypedia.com/companies/university-hospitals-cleveland-medical-center-irb/e78c4230-2786-4425-9ad7-f5e431913efd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
